How to Start a Peptide Telehealth Business: The Licensed Model

If you have been watching peptide telehealth companies grow and you want to build one, the first thing you need to understand is that you are not looking at an ecommerce store. You are looking at a licensed medical practice that works with a licensed pharmacy to prescribe and dispense pharmaceutical compounds to patients. That is a fundamentally different business from a research use only (RUO) peptide store, and the two cannot be merged, blended, or run from the same website, the same product catalog, or the same payment account. The moment a product moves from "for research use only" to "dispensed to a patient under a prescription," you are in a different business, and every layer of your business must reflect that.

We want to be direct with you before you go any further: this article is an operational orientation, not legal or medical advice, and it is written for founders who are trying to understand the shape of the business before they engage the attorneys, medical directors, and compliance consultants they will absolutely need. If you are currently running an RUO peptide store and you are thinking about adding a telehealth arm, stop and read this carefully. The two businesses must be separate legal entities with separate products, separate websites, and separate payment processing accounts. Mixing them puts both businesses at risk, so have your attorney explain how.

What a Peptide Telehealth Business Actually Is

A peptide telehealth business is, at its core, a medical practice that happens to deliver care remotely. Patients are evaluated by licensed clinicians, prescriptions are written, and those prescriptions are filled by a licensed pharmacy that ships directly to the patient. The peptide compounds involved are pharmaceutical grade compounds dispensed under a prescription, not research chemicals sold for laboratory use. This distinction is not semantic. Ask your attorney how it affects which regulators oversee you, which licenses you need, which payment processors you can use, and what your marketing can say.

The business model typically involves several interconnected entities. There is the clinical entity, which is the actual medical practice. There is the management or administrative entity, which handles non-clinical operations. There is the pharmacy relationship, which is a separate licensed business entirely. And there is the patient-facing technology layer, which is the telehealth platform through which patients interact with clinicians. Each of these layers has its own licensing, compliance, and operational requirements. None of them can be run the way you would run an RUO ecommerce store, where you are selling a product to a researcher and the transaction ends at checkout.

Understanding this structure before you spend a dollar on development or marketing is the most important thing we can tell you. Many founders come to this space from ecommerce backgrounds and they try to apply ecommerce logic to a healthcare business. That approach will cost you far more in remediation than it would have cost to build it correctly from the start.

The Roles That Must Be Licensed and Why Each One Matters

One of the most common mistakes founders make when entering the telehealth space is underestimating how many licensed professionals the business requires. This is not a business you can run with a single contractor and a Shopify store. Here is a plain-language breakdown of the key roles and what they require.

Prescribers licensed where the patient is located. Ask your attorney in which state each clinician who writes a prescription through your platform must be licensed. If your platform serves patients in multiple states, ask which prescriber licenses you need in each one, or whether to restrict your service to states where your prescribers are licensed. Building a state-by-state licensure map is one of the first operational tasks in your launch sequence.

A medical director. Plan for a medical director who provides clinical oversight for the practice, and confirm what each state requires with your attorney. Ask your attorney what responsibilities a medical director carries in each state where you plan to operate, and who can answer a regulator's questions about how clinical decisions are made. Finding a medical director who understands compounding pharmacy relationships and telehealth operations is not trivial. This is a specialized role and it requires a specialized search.

A licensed pharmacy that dispenses against prescriptions. Your prescribers prescribe, and your partner pharmacy dispenses. That function belongs entirely to a licensed pharmacy. The pharmacy receives the prescription, verifies it, compounds or sources the medication, and ships it to the patient. The pharmacy is a separate business, and your attorney can tell you which licenses and compliance obligations apply to it. In the structure this guide describes, you do not own or operate the pharmacy. What you do need is a pharmacy partner whose compliance posture you have thoroughly evaluated.

503A Compounding Pharmacies vs. 503B Outsourcing Facilities

When you evaluate pharmacy partners you will see two terms: 503A compounding pharmacy and 503B outsourcing facility. Both are sections of the Federal Food, Drug, and Cosmetic Act, and FDA describes the difference plainly. Section 503A "describes the conditions under which compounded human drug products are exempt from the FD&C Act sections on FDA approval prior to marketing, current good manufacturing practice (CGMP) requirements, and labeling with adequate directions for use." Section 503B created "a new, voluntary category of compounders known as outsourcing facilities." Unlike a 503A pharmacy, "outsourcing facilities are subject to CGMP requirements, and they may distribute compounded drugs either pursuant to a patient-specific prescription or in response to an order from a health care provider, such as a hospital, that is not for an identified individual patient (e.g., for office stock)." FDA also says outsourcing facilities "are inspected by FDA according to a risk-based schedule." In plain terms, a 503A pharmacy compounds for individual prescriptions under exemptions that include CGMP, and a 503B outsourcing facility is a registered category held to CGMP that may also fill provider orders. Ask your healthcare attorney which one fits your prescribing model.

We recommend reviewing the FDA's compounding pages directly rather than relying on summaries, and checking them again before you sign anything.

The FDA's Category 2 Bulk Drug Substances List

Know this before you sign a pharmacy partnership agreement. FDA has placed bulk drug substances that may present significant safety risks in category 2 under its interim policies. The FDA's page on this topic is titled "Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks" and it is available at https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks.

We are not going to name any substance on that list in this article, because naming substances is not the point. The point is this: any pharmacy partner you evaluate must be able to show you, in concrete terms, how they track that list and how they ensure they are not compounding substances that appear on it. This is not a question you ask once and forget. It is a question you build into your ongoing pharmacy partner review process. If a pharmacy cannot clearly explain their process for monitoring the Category 2 list, that is a serious red flag about their overall compliance posture.

The Management Services Organization Structure

Here is a structural question that surprises many founders who come from outside healthcare: whether your state lets a non-physician own a medical practice. You may hear this called the corporate practice of medicine doctrine. Ask a healthcare attorney how it applies in your state before you form any entity.

One structure to ask your attorney about is a Management Services Organization, or MSO. In this kind of arrangement, a separate management entity provides non-clinical services such as technology, marketing, billing support, and administrative operations to the clinical practice under a management services agreement, and the clinical entity keeps control of clinical decisions. Whether it works for you, and who may own which entity, depends on your state.

An MSO is not a loophole. How the arrangement works in practice matters, not only the paperwork.

We want to be very clear about what we are not doing here: we are not telling you how to structure your specific business. We describe the general concept so you know what to raise. Ask about physician ownership, professional corporations, and the permissible scope of management services agreements in each state where you plan to operate. You must confirm your specific state's requirements with a healthcare attorney who practices in that state before you form any entity or sign any agreement. See our guide at Peptide Business Attorney: When You Need One for how to find and evaluate an attorney for this type of work.

The management services agreement between the MSO and the clinical entity is a critical document. It defines what services the MSO provides, how the MSO is compensated, and what decisions remain exclusively with the clinical entity. Getting this agreement right requires experienced healthcare counsel. A generic business services agreement will not work.

Why Your RUO Store and Your Telehealth Business Must Be Completely Separate

Start with the rule that does not bend: never route research use only products into patient care. Those products are labeled not for human use, and supplying them to a prescriber, a pharmacy, or a patient contradicts that label. Under 21 CFR 201.128, "The intent may be shown by such persons' expressions, the design or composition of the article, or by the circumstances surrounding the distribution of the article." Ask your attorney what that means if a research product is supplied for patient care. Patients in a telehealth practice receive only what a licensed pharmacy dispenses under a prescription.

A research use only peptide store sells products that are explicitly not for human use. The products are labeled as such. The customers are researchers, laboratories, and institutions. The regulatory framework is different. The payment processing relationship is different. The marketing is different. The entire compliance posture is different.

A telehealth business whose clinicians prescribe peptide compounds that a partner pharmacy dispenses to patients is operating in a completely different regulatory environment. The products are pharmaceutical compounds dispensed under prescriptions. The customers are patients. Ask your attorney which agencies oversee this model, which advertising rules apply, and how payment processing differs.

If you run both businesses from the same website, someone reviewing your RUO store could question whether your RUO products are really meant for human use, because your other business sells similar compounds for human use.

Separate entities. Separate websites. Separate product catalogs. Separate payment accounts. Separate marketing. This is the separation we recommend to protect both businesses.

For the RUO side, including how to vet clinic buyers, see Selling Peptides to Clinics and Pharmacies.

Patient Privacy Obligations: HIPAA and Beyond

If your business handles patient health information, ask your attorney whether the Health Insurance Portability and Accountability Act, commonly known as HIPAA, applies to you, either as a covered entity or as a business associate. Do not assume a disclaimer on your website settles the question.

For a telehealth business, ask your attorney how HIPAA affects your telehealth platform, your patient intake forms, and your communications with patients, including emails and text messages. Ask your attorney which vendors, and which data flows with your pharmacy partner, need a Business Associate Agreement.

HIPAA is not a one-time setup task. An ongoing program usually covers training, risk assessments, written policies, and a process for breaches. Many telehealth founders underestimate the operational overhead of HIPAA compliance. Build it into your budget and your staffing plan from day one.

Beyond HIPAA, ask whether your states have their own health privacy laws. Your healthcare attorney should advise you on which state laws apply to your patient population and how they interact with HIPAA.

Ask your telehealth platform vendor whether it signs a Business Associate Agreement, and on which plan. Read it carefully. Understand what the vendor is and is not responsible for. Do not assume that using a HIPAA-compliant platform vendor means your business is HIPAA-compliant. The platform is one piece of the compliance picture. Your policies, your training, and your internal processes are the rest of it.

Payment Processing for Telehealth: What Founders Need to Know

Payment processing is one of the most practically challenging aspects of launching a telehealth business, and it is an area where many founders are caught off guard. Stripe lists "Telemedicine and telehealth services" among the restricted businesses in its restricted businesses policy, available at https://stripe.com/legal/restricted-businesses. Those categories require additional due diligence, so ask Stripe what review applies to you before you plan around it.

Other payment processors have their own telehealth policies, so read each one's current policy before you rely on it, and ask about documentation, reserves, and contract terms.

The practical implication is that you need to start your payment processor conversations early, before you launch, and you need to be completely transparent about what your business does. Do not try to hide the telehealth nature of your business to get approved faster.

For a deeper look at navigating high-risk payment processing in the peptide space, see our guide at What Payment Processor Can I Use to Sell Peptides?. While that guide is written with RUO stores in mind, many of the processor evaluation principles apply to telehealth as well.

When you are evaluating payment processors for your telehealth business, ask specifically about their experience with telehealth merchants, their chargeback thresholds, their reserve requirements, and their process for handling disputes that involve prescription transactions. A processor who has never worked with a telehealth business is not necessarily a bad choice, but you need to understand their learning curve and their risk tolerance before you commit.

Marketing Rules for Telehealth Businesses

Marketing a telehealth business is significantly more constrained than marketing an ecommerce store, and the constraints come from multiple directions simultaneously.

The FTC publishes a page titled "Health Products Compliance Guidance". Read it before you write any health related copy, and ask your attorney which FTC rules apply to your service.

Ask your healthcare attorney whether state medical board advertising rules apply to you, and have them review your marketing materials before you publish them.

If you are running paid advertising, you will encounter platform-specific restrictions as well. Each advertising platform has its own policies, so read each platform's current rules before you plan campaigns. Build time into your launch plan for getting your advertising accounts approved and your ad creative reviewed.

One specific area to be careful about: do not make any claim about the peptides your pharmacy partner compounds that could be read as a medical claim, an efficacy claim, or a health outcome claim. This applies to your website, your social media, your email marketing, your paid ads, and any content you publish. The fact that a compound is prescribed by a licensed clinician does not give you license to make marketing claims about what it does. Your marketing attorney and your medical director should both review any content that mentions specific compounds.

For more on the clinic-facing side of this business and how to think about the patient acquisition model, see our guide at How to Open a Peptide Clinic: Separate the Models.

Pharmacy Partner Diligence: What to Look For and What to Ask

Your pharmacy partner is one of the most important relationships in your telehealth business, and it is one that deserves a thorough diligence process before you sign anything. Here is a framework for evaluating pharmacy partners.

Licensing and accreditation. Ask for proof of current pharmacy licensure in every state where you intend to serve patients. Ask whether the pharmacy holds any accreditation from recognized pharmacy accreditation bodies. Ask specifically which United States Pharmacopeia (USP) standards they follow in compounding.

FDA inspection history. Ask whether the pharmacy has been inspected by the FDA and ask for any inspection reports or warning letters. A pharmacy that has received a warning letter is not automatically disqualified, but you need to understand what the warning letter said and what the pharmacy did in response. A pharmacy that has never been inspected and cannot explain why is a different kind of concern.

Category 2 bulk drug substance tracking. As we described earlier, ask specifically how the pharmacy tracks the FDA's Category 2 bulk drug substances list and how they ensure they are not compounding substances that appear on it. Ask who is responsible for monitoring the list, how often they check it, and what their process is when a substance is added to the list. A pharmacy that cannot answer this question clearly does not have a mature compliance program.

Quality control processes. Ask about the pharmacy's quality control testing for compounded medications. Ask whether they use third-party testing, and if so, ask for sample certificates of analysis. Ask about their beyond-use dating practices and how they determine stability for the compounds they produce.

Prescription workflow. Understand exactly how prescriptions flow from your platform to the pharmacy and back. Ask about turnaround times, how they handle prescription errors or clarifications, and how they communicate with prescribers when there is a clinical question. A pharmacy that cannot clearly describe its prescription workflow is not ready to be a telehealth partner.

Shipping and cold chain. Ask about storage, temperature control, cold chain management, and what happens when a shipment is delayed or damaged. Ask about their return and replacement policy for damaged shipments.

Insurance. Ask for proof of the pharmacy's professional liability insurance and general liability insurance. Understand what their coverage limits are and whether their coverage extends to claims arising from telehealth-related dispensing.

Business Insurance for a Telehealth Operation

Insurance for a telehealth business is more complex than insurance for a standard ecommerce store, and it is an area where founders often underestimate both the types of coverage they need and the cost of obtaining them.

At a minimum, a telehealth business should be thinking about professional liability insurance (also called malpractice insurance or errors and omissions insurance in the healthcare context), general liability insurance, cyber liability insurance, and directors and officers insurance. Depending on your structure, you may also need employment practices liability insurance and product liability insurance.

Professional liability insurance for a telehealth business covers claims arising from clinical errors or omissions. Ask your broker whether this coverage sits at the practice level, with each prescriber, or both. The cost and availability of this coverage varies significantly based on the types of services you offer, the states where you operate, and your claims history.

Cyber liability insurance is particularly important for telehealth businesses because of the volume of protected health information you will handle. Ask your attorney which notification duties and legal costs a data breach involving patient health information would bring. Cyber liability coverage can help offset those costs.

For a broader look at insurance considerations in the peptide business space, see our guide at Peptide Business Insurance: What a Policy Covers and What It Excludes.

The Numbered Launch Sequence

This is the operational sequence we recommend for founders who are serious about building a peptide telehealth business correctly. Each step has a pass or fail check. Do not move to the next step until you have passed the current one.

Step 1: Entity Structure

Engage a healthcare attorney to advise on the correct entity structure for your specific situation. This includes determining whether your state requires physician ownership of the medical practice, whether an MSO structure is appropriate, and how to structure the relationship between the clinical entity and the management entity.

Pass check: You have a written opinion from a licensed healthcare attorney confirming your entity structure is compliant with the corporate practice of medicine doctrine in each state where you intend to operate. You have formed the entities and have operating agreements or shareholder agreements in place.

Fail check: You have formed a single entity and plan to run both the clinical and management functions through it, or you have relied on a generic business attorney who does not specialize in healthcare law.

Step 2: Medical Director

Identify and engage a medical director who meets the requirements your attorney confirms for each launch state and who has experience with compounding pharmacy relationships and telehealth operations. Negotiate and execute a medical director agreement that clearly defines the scope of the medical director's responsibilities, their compensation, and the clinical protocols they will oversee.

Pass check: You have a signed medical director agreement with a licensed physician who has reviewed and approved your initial clinical protocols. Your medical director understands the compounding pharmacy relationship and has been briefed on the FDA's Category 2 bulk drug substances list.

Fail check: You have a verbal agreement with a physician who has agreed to "lend their name" to the practice without meaningful clinical involvement. Ask your attorney whether this arrangement is acceptable in your states; we would not rely on it.

Step 3: State Licensure Plan

Work with your healthcare attorney to develop a state-by-state licensure plan. Identify which states you will launch in, which states require specific telehealth licenses or registrations, and which states have restrictions on telehealth prescribing that may affect your service model. Identify the prescribers you will need in each state and confirm their licensure status.

Pass check: You have a written licensure plan that identifies every license, registration, or permit required in each launch state. You have confirmed that every prescriber on your platform is licensed in the states where they will see patients. You have a process for verifying patient location at the time of each consultation.

Fail check: You have assumed that your prescribers' existing licenses cover all the states where you want to serve patients, or you have not confirmed the telehealth-specific licensing requirements in your target states.

Step 4: Pharmacy Partner Diligence

Conduct the pharmacy partner diligence process described in the section above. Do not sign a pharmacy partnership agreement until you have received and reviewed all of the documentation described in that section.

Pass check: You have received proof of licensure, accreditation documentation (if applicable), FDA inspection history, a clear explanation of the pharmacy's Category 2 tracking process, sample certificates of analysis, and proof of insurance. Your healthcare attorney has reviewed the pharmacy partnership agreement.

Fail check: You have selected a pharmacy based on a sales conversation and a price quote without conducting document-level diligence. You have not asked about the Category 2 list. You have not had the partnership agreement reviewed by counsel.

Step 5: Patient Privacy Obligations

Engage a HIPAA compliance consultant or healthcare attorney to conduct a HIPAA risk assessment and help you develop the policies, procedures, and agreements required for compliance. This includes executing Business Associate Agreements with the vendors your attorney confirms need one, such as your telehealth platform.

Pass check: You have a completed HIPAA risk assessment, documented privacy and security policies, any patient privacy notices your attorney says you need, Business Associate Agreements with all relevant vendors, and a training plan for everyone who will handle protected health information.

Fail check: You have assumed that using a HIPAA-compliant platform vendor means your business is HIPAA-compliant. You have not executed Business Associate Agreements. You have not conducted a risk assessment.

Step 6: Payment Processing

Contact payment processors early in your launch process and disclose the telehealth nature of your business fully. As noted above, Stripe lists telemedicine and telehealth services as restricted businesses requiring additional due diligence. Evaluate multiple processors and understand their requirements, reserve policies, and chargeback thresholds before you commit.

Pass check: You have a payment processing account that has been approved for telehealth transactions, with documented approval from the processor. You understand the processor's reserve requirements and chargeback thresholds. You have a separate payment account for your telehealth business that is not connected to any RUO store you operate.

Fail check: You have signed up for a standard merchant account without disclosing the telehealth nature of your business. You are using the same payment account for your telehealth business and your RUO store.

Step 7: Marketing Rules

Have your marketing materials reviewed by both your healthcare attorney and your medical director before you publish anything. This includes your website, your social media profiles, your email templates, your paid ad creative, and any content you plan to publish. Ensure that no marketing material makes a medical claim, an efficacy claim, or a health outcome claim.

Pass check: Your website and all marketing materials have been reviewed and approved by your healthcare attorney and medical director. You have a documented process for reviewing new marketing content before it is published. Your advertising accounts have been approved for healthcare advertising where required.

Fail check: You have published marketing materials that make claims about what the compounds your pharmacy dispenses will do for patients. You have not had your marketing reviewed by counsel.

The Ongoing Compliance Posture

Launching a telehealth business is not a one-time compliance exercise. The rules for telehealth and compounding pharmacy can change, so check current rules. Here is what ongoing compliance looks like in practice.

Monitor the FDA's compounding-related communications. Check the FDA's compounding pages on a regular schedule for changes to the Category 2 bulk drug substances list and for other compounding notices. Someone in your organization needs to be responsible for monitoring these communications and ensuring that your pharmacy partner is aware of and responding to relevant changes.

Monitor state telehealth regulations. Ask your healthcare attorney to flag changes to telehealth rules in your operating states, such as prescribing rules, licensure requirements, and patient consent requirements.

Conduct regular pharmacy partner reviews. Your initial diligence on your pharmacy partner is not a permanent certification. Build a regular review cadence into your operations. At minimum, verify annually that your pharmacy partner's licenses are current, that their accreditation (if applicable) is current, and that they have not received FDA warning letters or state board actions since your last review.

Maintain your HIPAA compliance program. Review training, risk assessments and policies on the schedule your attorney sets. Do not treat your initial HIPAA setup as a permanent solution. The technology you use, the vendors you work with, and the types of data you handle will change over time, and your compliance program needs to change with them.

Review your marketing regularly. Check your marketing materials against current guidelines. When you add new services or compounds to your platform, have the related marketing reviewed before it goes live.

Common Structural Mistakes and How to Avoid Them

These are common structural mistakes to avoid. Here is a plain-language summary of the most common ones and what to do instead.

Mistake: Treating the telehealth business as an extension of an existing RUO store. This is the most common and most dangerous mistake. The two businesses are not extensions of each other. They are separate businesses that happen to operate in adjacent spaces. Keep them completely separate in every dimension: legal entity, website, product catalog, payment processing, marketing, and branding.

Mistake: Engaging a medical director who is not meaningfully involved in clinical oversight. Ask your attorney about the risk when a physician's name is on the practice but the physician has no real clinical involvement. A medical director who is not genuinely engaged in clinical oversight is not providing the protection you think they are. Find a medical director who will actually do the work.

Mistake: Assuming that a pharmacy's marketing materials are sufficient diligence. Every pharmacy will tell you they are compliant. Document-level diligence is the only way to verify that claim. Ask for the documents described in the pharmacy partner diligence section above, and have your attorney review the partnership agreement.

Mistake: Launching in too many states at once. The complexity of telehealth compliance scales with the number of states you operate in. Launching in a small number of states where you have strong prescriber relationships and clear regulatory guidance is a much more manageable starting point than trying to serve every state from day one.

Mistake: Underestimating the cost of compliance. Healthcare compliance is expensive. Attorney fees, compliance consultant fees, HIPAA infrastructure, insurance premiums, and the cost of maintaining licensed prescribers in multiple states add up quickly. Build a realistic compliance budget before you commit to this business model.

How This Business Compares to an RUO Peptide Store

For founders who are currently running or considering an RUO peptide store, it is worth being explicit about how different the telehealth model is across every operational dimension.

An RUO store sells products to researchers. A telehealth business provides medical services to patients. Each model has its own regulatory questions. For telehealth, bring state medical boards, state pharmacy boards, FDA compounding rules, HIPAA, advertising rules, and DEA rules to your attorney.

An RUO store can be launched with a relatively straightforward ecommerce setup. A telehealth business is built from a clinical entity, a management entity, a medical director, licensed prescribers, a pharmacy partner, a technology stack your attorney confirms for HIPAA, and a payment processor that accepts telehealth. Ask your attorney which of these your states require.

The revenue model is also different. An RUO store generates revenue from product sales. A telehealth business generates revenue from consultation fees, subscription plans, or a combination of both, with the pharmacy relationship structured separately. The margin profile, the chargeback risk, and the customer acquisition economics are all different.

None of this means the telehealth model is better or worse than the RUO model. They are different businesses with different risk profiles, different regulatory requirements, and different operational demands. The point is that you cannot apply the operational logic of one to the other.

Building the Right Team Before You Launch

The team required to launch a peptide telehealth business is meaningfully different from the team required to launch an RUO ecommerce store. Here is a plain-language description of the key roles you need to fill before you go live.

Healthcare attorney. This is the most important hire you will make. You need an attorney who specializes in healthcare law, who understands the corporate practice of medicine doctrine in your target states, who has experience with telehealth businesses, and who understands the compounding pharmacy regulatory environment. A general business attorney is not sufficient for this work. See our guide at Peptide Business Attorney: When You Need One for how to evaluate attorneys for this type of engagement.

Medical director. As described above, this is a licensed physician who will provide genuine clinical oversight for your practice. Finding the right medical director takes time. Start this search early.

HIPAA compliance consultant. Unless your healthcare attorney also specializes in HIPAA compliance (some do, many do not), you will likely need a separate HIPAA compliance consultant to help you build your privacy and security program.

Telehealth platform vendor. You need a technology platform that can support HIPAA-compliant video consultations, patient intake, prescription routing, and patient communication. There are vendors who specialize in this space. Evaluate them on their HIPAA compliance posture, their Business Associate Agreement terms, their integration capabilities, and their experience with compounding pharmacy workflows.

Billing and payment infrastructure. As discussed above, payment processing for telehealth requires specific setup. You may also need a billing system that can handle subscription plans, consultation fees, and the administrative complexity of a healthcare business.

Marketing and compliance reviewer. Someone needs to be responsible for ensuring that all marketing materials are reviewed before publication. This can be a function of your healthcare attorney, your medical director, or a dedicated compliance officer, but it cannot be an afterthought.

Frequently Asked Questions

Can I just add a telehealth section to my existing RUO peptide website?

No. This is one of the most important things to understand before you start building. A telehealth business whose clinicians prescribe compounds that a partner pharmacy dispenses to patients must be completely separate from an RUO peptide store. Separate legal entity, separate website, separate product catalog, separate payment processing accounts, and separate marketing. Combining them is a risk for both businesses.

Do I need a medical director even if I am hiring licensed prescribers?

Plan for one, and have your attorney confirm what your states require. Licensed prescribers handle individual patient consultations and write prescriptions. A medical director provides clinical oversight for the practice as a whole, including developing and maintaining clinical protocols and conducting quality assurance reviews. These are different functions and they are both necessary. A prescriber who sees patients is not automatically providing the practice-level oversight that a medical director provides.

What is the difference between a 503A pharmacy and a 503B outsourcing facility, and which one should I use?

A 503A pharmacy compounds under exemptions from FDA approval, CGMP and certain labeling requirements. A 503B outsourcing facility is a voluntary FDA category that is subject to CGMP and may fill patient-specific prescriptions or provider orders for office stock. Which type fits your model is a decision for your healthcare attorney and medical director. Do not choose on price alone.

How do I know if a pharmacy partner is actually compliant?

You verify compliance through document-level diligence, not through sales conversations or marketing materials. Ask for proof of current licensure in all relevant states, FDA inspection history, their process for tracking the FDA's Category 2 bulk drug substances list, quality control documentation including sample certificates of analysis, and proof of insurance. Have your healthcare attorney review the partnership agreement before you sign it. A pharmacy that cannot or will not provide this documentation is not a pharmacy you should be working with.

Will Stripe work for my telehealth business?

Stripe lists telemedicine and telehealth services as restricted businesses in its restricted businesses policy, and those categories require additional due diligence. Ask Stripe what additional review applies to you and be fully transparent about what your business does. Whether Stripe ultimately approves your business is not something we can predict. Start your payment processor conversations early and evaluate multiple options.

Do I need separate insurance for the telehealth business versus my RUO store?

Yes. The insurance needs of a telehealth business are fundamentally different from those of an RUO store. A telehealth business needs professional liability insurance (malpractice coverage), cyber liability insurance given the volume of patient health information involved, and potentially other coverages that an RUO store would not need. Do not assume that your existing business insurance covers your telehealth operations. Have your insurance broker review your coverage needs specifically for the telehealth entity. See our guide at Peptide Business Insurance: What a Policy Covers and What It Excludes for more on insurance considerations in this space.

Can I own the pharmacy that my telehealth business works with?

This is a question with a complex answer that depends on your state's laws, your professional licensure status, and how the ownership structure is set up. Ask a healthcare attorney about pharmacy ownership rules, anti-kickback rules, and fee splitting rules. This is a question you must answer with a healthcare attorney who specializes in pharmacy law, not a question to answer based on general business logic.

How long does it realistically take to launch a peptide telehealth business?

There is no single answer because the timeline depends on your starting point, your target states, the availability of a medical director, and the complexity of your entity structure. What we can tell you is that rushing this process tends to create problems that cost more time and money to fix than the rush saved. The entity formation, attorney engagement, medical director search, state licensure planning, pharmacy partner diligence, and HIPAA compliance setup are all processes that take time to do correctly. Build a realistic timeline that accounts for all of them.

If you are serious about building a peptide telehealth business and you want to pressure-test your plan before you commit significant capital, we invite you to book a fit call at peptideecommerce.com. On the call we can help you identify the questions you need to be asking before you start spending.

Sources

• FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks: https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
• Stripe, Restricted Businesses: https://stripe.com/legal/restricted-businesses
• FDA, Human Drug Compounding Laws: https://www.fda.gov/drugs/human-drug-compounding/human-drug-compounding-laws
• FTC, Health Products Compliance Guidance: https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance

This article is not legal advice. It is general information, not legal, medical, regulatory, or compliance advice. Consult qualified legal counsel and healthcare compliance professionals for guidance specific to your business and jurisdiction.